-
Intratympanic Steroid Treatment versus Intratympanic Steroid and Diuretics Combination Treatment in Patients with Acute Low Frequency Sensorineural Hearing Loss with Vertigo
-
Hyeon Sik Oh, Hyun Joon Shim, Yong-Hwi An
-
Res Vestib Sci. 2017;16(3):85-91. Published online September 15, 2017
-
DOI: https://doi.org/10.21790/rvs.2017.16.3.85
-
-
 Abstract
 PDF
- Objectives
Intratympanic dexamethasone (ITD) is a standard treatment for patients with sudden sensorineural hearing loss. The aim of this study was to evaluate the effectiveness of ITD vs. combination of ITD and diuretics for acute low frequency sensorineural hearing loss (LFHL) with vertigo. Methods: A total 31 patients with LFHL that had developed within previous 2 weeks were enrolled and categorized into two groups: treated with ITD four times on 4 consecutive days (ITD group; 17 patients) and treated with ITD in the same way and diuretics orally for 2 weeks (combination group; 14 patients). After 6 months, we analyzed treatment outcomes using subjective improvement and audiometric change. Results: Hearing thresholds at low frequencies ≤500 Hz were significantly improved in both ITD only and combination group (p＜0.05). The cure rate of combination group was not significantly higher than that of ITD only group (57.1% vs. 52.9%, p＞0.05). For subjective symptoms, there were no significant differences of improvement rate in both groups (combination 64.3% vs. ITD only 64.7%, p＞0.05). In pure tone audiometry, the improvement rate of combination group was not significantly different from that of ITD only group (71.4% vs. 76.5%, p＞0.05). There was a significant correlation between the complete recovery rate and duration of symptoms. Conclusion: ITD alone is an effective treatment modality for acute LFHL with vertigo within 2 weeks of development. Combined ITD and diuretics have no additive effect for the recovery of hearing in patients with LFHL.
-
Intra-tympanic Steroid Treatment vs Intra-tympanic Steroid and Diuretics Combination Treatment in Patients with Acute Low Frequency Sensorineural Hearing Loss with Vertigo
-
Hyeon Sik Oh, Hyun Joon Shim, Yong-Hwi An
-
Received May 31, 2017 Accepted August 23, 2017 Published online August 23, 2017
-
[Accepted]
-
-
Abstract
- Objectives
Intra-tympanic dexamethasone (ITD) is a standard treatment for patients with sudden sensorineural hearing loss. The aim of this study was to evaluate the effectiveness of ITD vs combination of ITD and diuretics for acute low frequency sensorineural hearing loss (LFHL) with vertigo.
Methods
A total 31 patients with LFHL that had developed within previous 2 weeks were enrolled and categorized into two groups: 1) treated with ITD four times on 4 consecutive days (ITD group; 17 patients) and 2) treated with ITD in the same way and diuretics orally for 2 weeks (combination group; 14 patients). After 6 months, we analyzed treatment outcomes using subjective improvement and audiometric change.
Results
Hearing thresholds at low frequencies ≤ 500 Hz were significantly improved in both ITD only and combination group (p<0.05). The cure rate of combination group was not significantly higher than that of ITD only group (57.1% vs. 52.9%, p>0.05). For subjective symptoms, there were no significant differences of improvement rate in both groups (combination 64.3% vs. ITD only 64.7%, p>0.05). In pure tone audiometry, the improvement rate of combination group was not significantly different from that of ITD only group (71.4 vs. 76.5%, p>0.05). There was a significant correlation between the complete recovery rate and duration of symptoms.
Conclusions
ITD alone is an effective treatment modality for acute LFHL with vertigo within 2 weeks of development. Combined ITD and diuretics have no additive effect for the recovery of hearing in patients with LFHL.
|
KBS
